Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Reinvestment Rate
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Reinvestment Rate of 1.66x as of September 2025, reinvesting CN¥47.02 Million (capex CN¥47.02 Million ) from operating cash flow of CN¥28.39 Million. Check Hangzhou Biotest Biotech Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Explore cash flow to debt ratio of Hangzhou Biotest Biotech Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Hangzhou Biotest Biotech Co Ltd. For live market cap and broader valuation context, see market value of Hangzhou Biotest Biotech Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.65x | CN¥388.70 Million | CN¥106.47 Million | CN¥129.87 Million | ▼ -43.9% |
| 2024 | 6.51x | CN¥838.33 Million | CN¥128.83 Million | CN¥245.05 Million | ▲ +553.7% |
| 2023 | 1.00x | CN¥130.79 Million | CN¥131.38 Million | CN¥56.42 Million | ▲ +154.0% |
| 2022 | 0.39x | CN¥275.63 Million | CN¥703.21 Million | CN¥178.92 Million | ▼ -55.5% |
| 2021 | 0.88x | CN¥800.17 Million | CN¥908.12 Million | CN¥200.20 Million | ▲ +245.5% |
| 2020 | 0.26x | CN¥113.76 Million | CN¥446.07 Million | CN¥57.68 Million | ▼ -91.7% |
| 2019 | 3.08x | CN¥78.94 Million | CN¥25.67 Million | CN¥39.47 Million | ▲ +414.0% |
| 2018 | 0.60x | CN¥12.67 Million | CN¥21.17 Million | CN¥12.67 Million | ▼ -83.9% |
| 2017 | 3.73x | CN¥26.37 Million | CN¥7.07 Million | CN¥26.37 Million | — |